These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32851051)

  • 21. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge.
    Borrego B; Argilaguet JM; Pérez-Martín E; Dominguez J; Pérez-Filgueira M; Escribano JM; Sobrino F; Rodriguez F
    Antiviral Res; 2011 Nov; 92(2):359-63. PubMed ID: 21820470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
    Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
    Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
    Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
    Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Designing Functionally Versatile, Highly Immunogenic Peptide-Based Multiepitopic Vaccines against Foot-and-Mouth Disease Virus.
    Defaus S; Forner M; Cañas-Arranz R; de León P; Bustos MJ; Rodríguez-Pulido M; Blanco E; Sobrino F; Andreu D
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32707834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a conserved linear epitope using monoclonal antibody against non-structural protein 3A of foot-and-mouth disease virus with potential for differentiation between infected and vaccinated animals.
    Wang M; Xu Z; Liu W; Li M; Wang H; Yang D; Ma W; Zhou G; Yu L
    Res Vet Sci; 2019 Jun; 124():178-185. PubMed ID: 30904721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes.
    Li G; Chen W; Yan W; Zhao K; Liu M; Zhang J; Fei L; Xu Q; Sheng Z; Lu Y; Zheng Z
    Virology; 2004 Oct; 328(2):274-81. PubMed ID: 15464847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine.
    Gerner W; Denyer MS; Takamatsu HH; Wileman TE; Wiesmüller KH; Pfaff E; Saalmüller A
    Virus Res; 2006 Nov; 121(2):223-8. PubMed ID: 16934904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
    Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
    Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
    Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
    J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
    Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
    Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
    Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
    Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin.
    Cui B; Liu X; Zhou P; Fang Y; Zhao D; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3367-3379. PubMed ID: 30888465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.
    Snijders A; Benaissa-Trouw BJ; Snippe H; Kraaijeveld CA
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2267-72. PubMed ID: 1383405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificially designed recombinant protein composed of multiple epitopes of foot-and-mouth disease virus as a vaccine candidate.
    Lee HB; Piao DC; Lee JY; Choi JY; Bok JD; Cho CS; Kang SK; Choi YJ
    Microb Cell Fact; 2017 Feb; 16(1):33. PubMed ID: 28228147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination].
    Ma M; Jin N; Yin G; Lu H; Li C; Jin K; Qu Z
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):514-9. PubMed ID: 19637624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between efficacy and structure of recombinant epitope vaccines against bovine type O foot and mouth disease virus.
    Fang M; Li J; Wang H; Yang M; Zhang Y; Zhou L; Wei H; Yang G; Yu Y; Wei X; Yu Y; Wang L; Wan M
    Biotechnol Lett; 2012 May; 34(5):839-47. PubMed ID: 22286179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen.
    Terasawa H; Tsang KY; Gulley J; Arlen P; Schlom J
    Clin Cancer Res; 2002 Jan; 8(1):41-53. PubMed ID: 11801539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mapping major and minor T-cell epitopes in vitro and their immunogenic or tolerogenic effect in vivo in non-human primates.
    Walker PR; Smerdon R; Haron J; Lehner T
    Immunology; 1993 Oct; 80(2):209-16. PubMed ID: 7505256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.